Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Exploratory Grants (P20)
Project #
1P20CA058203-01
Application #
3100586
Study Section
Special Emphasis Panel (SRC (50))
Project Start
1992-09-30
Project End
1995-09-29
Budget Start
1992-09-30
Budget End
1993-09-29
Support Year
1
Fiscal Year
1992
Total Cost
Indirect Cost
Name
Dana-Farber Cancer Institute
Department
Type
DUNS #
149617367
City
Boston
State
MA
Country
United States
Zip Code
02215
Jacobs, T W; Siziopikou, K P; Prioleau, J E et al. (1998) Do prognostic marker studies on core needle biopsy specimens of breast carcinoma accurately reflect the marker status of the tumor? Mod Pathol 11:259-64
Jin, L; Fuchs, A; Schnitt, S J et al. (1997) Expression of scatter factor and c-met receptor in benign and malignant breast tissue. Cancer 79:749-60
Jacobs, T W; Prioleau, J E; Stillman, I E et al. (1996) Loss of tumor marker-immunostaining intensity on stored paraffin slides of breast cancer. J Natl Cancer Inst 88:1054-9
Siziopikou, K P; Prioleau, J E; Harris, J R et al. (1996) bcl-2 expression in the spectrum of preinvasive breast lesions. Cancer 77:499-506
Mashal, R D; Koontz, J; Sklar, J (1995) Detection of mutations by cleavage of DNA heteroduplexes with bacteriophage resolvases. Nat Genet 9:177-83
Elson, A; Leder, P (1995) Protein-tyrosine phosphatase epsilon. An isoform specifically expressed in mouse mammary tumors initiated by v-Ha-ras OR neu. J Biol Chem 270:26116-22
Elson, A; Leder, P (1995) Identification of a cytoplasmic, phorbol ester-inducible isoform of protein tyrosine phosphatase epsilon. Proc Natl Acad Sci U S A 92:12235-9